Related Experiment Video
Updated: Jun 26, 2026

09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Large left ventricular metastasis causing left ventricular outflow tract obstruction and haemolysis
J M Coller1, P Parente, D Esmore
1Box Hill Hospital, Victoria, Australia. jencoller2003@yahoo.com.au
Summary
A rare symptomatic cardiac metastasis from fibrosarcoma caused significant heart obstruction. Echocardiography diagnosed this unusual ventricular tumor 9 years after initial treatment.
Area of Science:
- Cardiology
- Oncology
- Medical Imaging
Background:
- Cardiac metastases are often clinically silent and underdiagnosed.
- Echocardiography screening is limited, typically reserved for patients receiving cardiotoxic chemotherapy.
- Advances in cancer therapies may alter the natural history of metastatic disease, potentially increasing recognition of rare presentations.
Observation:
- A solitary, large ventricular metastasis caused left ventricular outflow tract obstruction and hemodynamic compromise.
- The metastasis was a recurrence of soft-tissue fibrosarcoma, diagnosed 9 years after the primary tumor resection.
- This case represents a rare instance of a symptomatic ventricular metastasis without other signs of metastatic disease.
Findings:
- Echocardiographic imaging was crucial for diagnosing the ventricular metastasis.
- The metastasis led to significant left ventricular outflow tract obstruction.
- The patient's presentation was unusual due to the solitary, symptomatic nature of the cardiac metastasis.
Implications:
- Highlights the importance of considering cardiac metastasis in patients with unexplained hemodynamic compromise, even in the absence of widespread disease.
- Suggests that echocardiography may have a role in evaluating unexplained cardiac symptoms in cancer survivors.
- Underscores the evolving landscape of cancer metastasis with novel therapeutic agents potentially changing disease presentation and prognosis.
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

